Watch Ticker

Aligos Therapeutics, Inc. Common Stock

Go to Aligos Therapeutics, Inc. Common Stock Website

$0.00

(%)
Live
Previous Close

$

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$51.2 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for no...

Community
  • 0 posts discussing
0

Watchers

0

Visitors

Recent News

Aligos Therapeutics (ALGS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Related tickers: ALGS.

Read Full Article

SOUTH SAN FRANCISCO, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced that it will report the Company’s first quarter 2024 financial results on Tuesday, May 7, 2024, after the close of the U.S. financial markets.

Related tickers: ALGS.

Read Full Article
Trending Tickers
ITOS

XNAS

$17.90
(%)
MIMO

XASE

$0.11
(%)
PRSO

XNAS

$1.40
(%)
QQQ

XNAS

$451.98
(%)
FDXTF

$0.00
(%)